Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01745627 · ClinicalTrials.gov registry record · NA
755nm Alex Laser for Treatment of Pigmented and Vascular Lesions and Scars
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT01745627: Completed NA study, sponsored by Cynosure.
NCT01745627 is a NA study that has completed, run by Cynosure. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01745627, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
Evaluation of the safety and efficacy of the 755nm Alex laser for the treatment of benign pigmented and vascular lesions and scars
Primary Outcome
This scale ranges from 0 to 3, where 0 is 0-25% clearance, 1 is 26-50% clearance, 2 is 51-75% clearance and 3 is 76-100% clearance. The baseline picture was compared to a photograph taken at the follow up visit. The number of patients that fell into each category was recorded.
Interventions
- DEVICE 755nm Alex laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT01745627 record still lists
NCT01745627 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which 755nm Alex laser is the first listed.
NCT01745627 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01745627 about?
NCT01745627 is a clinical study titled "755nm Alex Laser for Treatment of Pigmented and Vascular Lesions and Scars". Evaluation of the safety and efficacy of the 755nm Alex laser for the treatment of benign pigmented and vascular lesions and scars
What is the current status of trial NCT01745627?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2011-10. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01745627?
The interventions under investigation include: 755nm Alex laser (DEVICE).
Who is sponsoring clinical trial NCT01745627?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01745627's enrollment target sits among peer trials
43 1435th of 2000 higher than 565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia